InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Monday, 02/05/2018 1:56:47 PM

Monday, February 05, 2018 1:56:47 PM

Post# of 239
AACR Wednesday, February 14

B07 Immunologic activation in recurrent high-grade glioma patients with durable complete response
following treatment with Toca 511 and Toca FC. Clark Chen, University of Minnesota, Minneapolis, MN.

B08 Toca 511 and Toca FC: Durable complete responses observed in patients with IDH1 wild-type
and mutant recurrent high-grade glioma (rHGG). Bob Carter, Massachusetts General Hospital, Boston,
MA

http://www.aacr.org/Documents/CNS_Poster%20Session%20B_website.pdf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOCA News